Uterine fibroids, also known as myomas or leiomyomas, are benign tumors that grow within or outside the wall of the uterus. They are made up of smooth muscle and fibrous connective tissue. Uterine fibroids affect around 70-80% of women by the age of 50. While they are usually asymptomatic, some women experience heavy menstrual bleeding, pelvic pain or pressure, frequent urination, difficulty emptying bladder and painful intercourse due to fibroids. Fibroids can vary from microscopic to several centimeters in diameter and most women have single or multiple fibroids. The exact cause of uterine fibroids is unknown but genetics, hormonal factors, age and obesity are believed to play a role in their formation and growth.
Diagnosis and Treatment Options for Fibroids
Uterine fibroids are usually diagnosed during a pelvic exam or through imaging tests like ultrasound, MRI etc. The treatment options depend on a woman's symptoms, size and location of fibroids and her desire to have children in the future. Some treatment options for fibroids include myomectomy, hysterectomy, uterine artery embolization, MRI-guided focused ultrasound and medication therapy. Myomectomy, which is the surgical removal of fibroids, has gained popularity as a minimally invasive treatment which allows women to preserve their uterus and fertility.
Techniques Used for Myomectomy Industry
There are different techniques used for removing fibroids through Myomectomy depending on their location and size. Abdominal myomectomy involves making an incision in the lower abdomen to access the uterus. It is suitable for large or multiple fibroids. Laparoscopic myomectomy is done through small incisions using thin, lighted instruments and a tiny camera. Robotic myomectomy uses a robotic system to guide the surgeon's movements through even smaller incisions. It provides greater precision, accuracy and flexibility. Hysteroscopic myomectomy involves removing fibroids through the cervix with a specialized camera called a hysteroscope. This is suitable only for submucosal fibroids located within the uterine cavity. The choice of technique depends on the expertise of the surgeon.
Global Trends in Myomectomy
Myomectomy is becoming an increasingly popular treatment for fibroids worldwide due to advantages like uterus preservation and lesser recovery time than abdominal surgery. In the United States, it is estimated that over 100,000 myomectomies are performed each year with the number rising steadily. There has also been a significant increase in minimally invasive techniques like laparoscopic and robotic myomectomy, especially in developed countries. Countries in Asia, Africa and South America are also seeing a growing demand for fibroid treatments as awareness increases. Medical tourism has enabled women from different parts of the world to access advanced fibroid surgeries like robotic myomectomy in countries like India and Turkey at affordable costs. However, uterine fibroids remain under-diagnosed and under-treated in many low-income regions due to lack of screening programs and resources.
Robotic Myomectomy: Future of Minimally Invasive Surgery
Robotic myomectomy is fast becoming the preferred treatment modality in many parts of the developed world due to advantages over traditional and laparoscopic surgery. Robotic systems offer 10X magnification, tremor filtration and wristed instruments that mimic the human hand. This translates to better ergonomics, precision and control for the surgeon. Smaller incisions result in less blood loss, less scarring and quicker recovery times for patients. Advanced 3D cameras and access through multiple ports enable complex surgeries to be performed with greater ease than laparoscopy. Robotic myomectomy studies show favorable short-term outcomes like reduced hospital stay and return to normal activity. Longer term data also indicates similar fertility rates and fewer complications compared to open surgery. Its benefits are driving more gynecologic procedures to incorporate robotic technology. However, the high costs of robotics limit its widespread adoption globally currently. As technology advances and costs reduce, robotic myomectomy is positioned to become the gold standard minimally invasive treatment for fibroids worldwide in the future.
Uterine fibroids are a very common gynecological condition affecting women's quality of life. With growing awareness and treatment options, myomectomy has emerged as an effective standard of care for symptomatic fibroids while preserving the uterus. Minimally invasive techniques like laparoscopy and robotics are reducing recovery times and improving outcomes. Developing nations are also seeing increased access to fibroid surgeries. Overall, robotic myomectomy shows promise as the future of minimally invasive fibroid treatment globally as technology progresses further.
Get More Insights on- Myomectomy
For Deeper Insights, Find the Report in the Language that You want:
About Author:
Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.
(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/)
Naijamatta is a social networking site,
download Naijamatta from Google play store or visit www.naijamatta.com to register. You can post, comment, do voice and video call, join and open group, go live etc. Join Naijamatta family, the Green app.
Click To Download
